REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.
Also called NCT01353586
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 186 participants
- Sponsor
- Registry
-
NCT01353586
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Czechia, Denmark, France, Germany, Italy
- Registry status
- Completed
Technical summary
Registry record NCT01353586. Allocation not applicable; no masking; primary purpose treatment. Start 2011-03-01 (actual); primary completion 2013-09-01 (actual). Results posted on 2016-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation
- Acronym
- REVOLUTION
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- nMARQ™ System
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct01353586- Content hash
2db25ecd2c652c928af4f442c44d4c4e2c579f27e6f1e43cbaff5eeb04870f10